On ECHEMI
Home > Drugs > Chongqing Qingyang Pharmaceutical Co., Ltd.
Chongqing Qingyang Pharmaceutical Co., Ltd.
  • Founded in:

    2002-05-21
  • Country:

    China China
  • Address:

    Room 7-1, Building 1, No. 2, Gang'an 2nd Road, Jiangbei District, Chongqing
  • Tax NO.:

    915001057365937855
  • Registered Funds:

    100.764 million yuan
  • Website:

  • Email:

Related Drugs
Compound Bergenia tablets
This product is a compound preparation, the components are: each tablet contains 125 mg of bergenin and 2 mg of chlorpheniramine maleate.
Name Description Content CAS NO. Registered Holders
Bengenin

It has good antitussive and expectorant effects on chronic bronchitis

More

It has good antitussive and expectorant effects on chronic bronchitis

125mg 477-90-7 0
Chlorphenamine maleate

It has a strong histamine H1 receptor blocking effect, can alleviate other respiratory symptoms caused by allergies, and also has a mild inhibitory effect on the central nervous system

More

It has a strong histamine H1 receptor blocking effect, can alleviate other respiratory symptoms caused by allergies, and also has a mild inhibitory effect on the central nervous system

2mg 113-92-8 28
Tolbutamide Tablets
Tolbutamide
Name Description Content CAS NO. Registered Holders
TOLBUTAMIDE

This product is a hypoglycemic drug. 1. It stimulates the pancreatic islet beta cells to secrete insulin, which presupposes that the islet beta cells also have a certain ability to synthesize and secrete insulin; 2. It inhibits liver glycogenolysis and gluconeogenesis by increasing portal vein insulin levels or directly acting on the liver, and reduces the generation and output of glucose in the liver; 3. It may also increase the sensitivity of extrapancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to reduce fasting blood sugar and postprandial blood sugar.

More

This product is a hypoglycemic drug. 1. It stimulates the pancreatic islet beta cells to secrete insulin, which presupposes that the islet beta cells also have a certain ability to synthesize and secrete insulin; 2. It inhibits liver glycogenolysis and gluconeogenesis by increasing portal vein insulin levels or directly acting on the liver, and reduces the generation and output of glucose in the liver; 3. It may also increase the sensitivity of extrapancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to reduce fasting blood sugar and postprandial blood sugar.

64-77-7 16
Enoxacin Tablets
Enoxacin.
Name Description Content CAS NO. Registered Holders
Enoxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

74011-58-8 4
Famotidine tablets
Main ingredients: The main ingredient is: famotidine. Its chemical name is: 3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N-sulfamoylpropionamidine. Molecular formula: C8H15N7O2S3 Molecular weight: 337.45
Name Description Content CAS NO. Registered Holders
Famotidine

It has a significant inhibitory effect on gastric acid secretion and can also inhibit the secretion of pepsin.

More

It has a significant inhibitory effect on gastric acid secretion and can also inhibit the secretion of pepsin.

76824-35-6 69
Domiphene lozenges
This product is a compound preparation, the main ingredient of which is domiphene. Each tablet contains 0.5 mg of domiphene, and the auxiliary ingredients are sucrose, dextrin, sunset yellow, menthol, and talcum powder.
Name Description Content CAS NO. Registered Holders
Domiphen bromide

This product is a cationic surfactant with broad-spectrum bactericidal effect

More

This product is a cationic surfactant with broad-spectrum bactericidal effect

0.5mg 0
Sucrose

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

57-50-1 71
Dextrin

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

9004-53-9 50
Sunset Yellow FCF

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

2783-94-0 1
DL-Menthol

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

89-78-1 8
Talc

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

14807-96-6 26
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.